B cell terminal differentiation factor XBP-1 induces reactivation of Kaposi's sarcoma-associated herpesvirus.
about
KSHV: pathways to tumorigenesis and persistent infectionInterplay of Murine Gammaherpesvirus 68 with NF-kappaB Signaling of the HostThe B-cell specific transcription factor, Oct-2, promotes Epstein-Barr virus latency by inhibiting the viral immediate-early protein, BZLF1KSHV infects a subset of human tonsillar B cells, driving proliferation and plasmablast differentiation.Gammaherpesvirus-driven plasma cell differentiation regulates virus reactivation from latently infected B lymphocytes.The murine gammaherpesvirus immediate-early Rta synergizes with IRF4, targeting expression of the viral M1 superantigen to plasma cellsViral latency and its regulation: lessons from the gamma-herpesviruses.Resveratrol inhibits KSHV reactivation by lowering the levels of cellular EGR-1Human herpesvirus 8 induces polyfunctional B lymphocytes that drive Kaposi's sarcomaLack of XBP-1 impedes murine cytomegalovirus gene expression.Immune evasion by Kaposi's sarcoma-associated herpesvirus.Mechanisms of Kaposi's Sarcoma-Associated Herpesvirus Latency and ReactivationMurine gammaherpesvirus M2 protein induction of IRF4 via the NFAT pathway leads to IL-10 expression in B cellsGCN5 inhibits XBP-1S-mediated transcription by antagonizing PCAF actionInterleukin 21 signaling in B cells is required for efficient establishment of murine gammaherpesvirus latencyComparison of humoral immune responses to Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus using a viral proteome microarray.ORF45-Mediated Prolonged c-Fos Accumulation Accelerates Viral Transcription during the Late Stage of Lytic Replication of Kaposi's Sarcoma-Associated Herpesvirus.Modulation of Immune System by Kaposi's Sarcoma-Associated Herpesvirus: Lessons from Viral Evasion Strategies.Activation of the unfolded protein response by 2-deoxy-D-glucose inhibits Kaposi's sarcoma-associated herpesvirus replication and gene expression.Amplification of JNK signaling is necessary to complete the murine gammaherpesvirus 68 lytic replication cycle.Induction of Kaposi's Sarcoma-Associated Herpesvirus-Encoded Viral Interleukin-6 by X-Box Binding Protein 1.The product of Kaposi's sarcoma-associated herpesvirus immediate early gene K4.2 regulates immunoglobulin secretion and calcium homeostasis by interacting with and inhibiting pERP1.A critical Sp1 element in the rhesus rhadinovirus (RRV) Rta promoter confers high-level activity that correlates with cellular permissivity for viral replication.AKTivation of PI3K/AKT/mTOR signaling pathway by KSHV.X box binding protein XBP-1s transactivates the Kaposi's sarcoma-associated herpesvirus (KSHV) ORF50 promoter, linking plasma cell differentiation to KSHV reactivation from latency.Activation of the B cell antigen receptor triggers reactivation of latent Kaposi's sarcoma-associated herpesvirus in B cells.Wide-scale use of Notch signaling factor CSL/RBP-Jkappa in RTA-mediated activation of Kaposi's sarcoma-associated herpesvirus lytic genesVirus-Like Vesicles of Kaposi's Sarcoma-Associated Herpesvirus Activate Lytic Replication by Triggering Differentiation Signaling.Identification of Novel Kaposi's Sarcoma-Associated Herpesvirus Orf50 Transcripts: Discovery of New RTA Isoforms with Variable Transactivation Potential.ARID3B: a Novel Regulator of the Kaposi's Sarcoma-Associated Herpesvirus Lytic Cycle.Murine gammaherpesvirus 68 reactivation from B cells requires IRF4 but not XBP-1.Cdk1 inhibition induces mutually inhibitory apoptosis and reactivation of Kaposi's sarcoma-associated herpesvirus.X-box binding protein 1 induces the expression of the lytic cycle transactivator of Kaposi's sarcoma-associated herpesvirus but not Epstein-Barr virus in co-infected primary effusion lymphoma.Blimp-1-dependent plasma cell differentiation is required for efficient maintenance of murine gammaherpesvirus latency and antiviral antibody responses.X-box binding protein 1 contributes to induction of the Kaposi's sarcoma-associated herpesvirus lytic cycle under hypoxic conditions.Kaposi's sarcoma-associated herpesvirus RTA promotes degradation of the Hey1 repressor protein through the ubiquitin proteasome pathwayZIC2 is Essential for Maintenance of Latency and is a Target of an Immediate-Early Protein during KSHV Lytic Reactivation.Murine gammaherpesvirus M2 antigen modulates splenic B cell activation and terminal differentiation in vivo.The human cytomegalovirus UL112-113 locus can activate the full Kaposi's sarcoma-associated herpesvirus lytic replication cycleOxidative stress induces reactivation of Kaposi's sarcoma-associated herpesvirus and death of primary effusion lymphoma cells.
P2860
Q27026000-02780D83-939F-4FC7-876A-0029727E7086Q28080198-080723D8-280C-411A-AD43-31C272A495DEQ28480586-9B281787-DF6F-413B-AE3B-71C71CEB7F8FQ30433391-DD40B066-377C-444E-97CF-3B5D8202299CQ30943994-A25919FE-B15E-4D5D-888B-679CB23BC00FQ34015827-2E818412-0687-4CFD-8475-BC2C08C2F2BFQ34039189-03D9FD5F-B342-4B5E-9FE1-E7888434BA1CQ34200840-B1B5632C-F5D7-46D4-8AFA-CF000D738E36Q34237804-5A976716-3ACA-4FE4-A6D9-A5066086FB5FQ34380313-D5109522-19D6-464D-A9DB-9AD94BC82879Q34795543-189C6E2B-1D2E-4761-9992-1EAC69774B14Q35010647-CCB99268-44B6-477E-86B2-D21AB5E32F3BQ35082220-1197C510-3297-4888-987D-1A4F1743D342Q35238447-8D013F5B-3040-4689-8FEB-336EBC15792AQ35392834-8F5BB6CE-3BCA-47A9-A988-33A247EE6CBCQ35463816-B0F883F7-973D-4A56-A448-CDAD94F5E8CAQ35745462-6F989C08-395C-4770-AD9A-9F9A211D4773Q35801076-BDABB398-6751-432E-B25D-0AABBDCD8664Q36364238-73F6065C-FDB5-4FB9-BB63-0CC24A9C9CA5Q36414290-1F6078C0-4A6C-48AC-A95F-A3D5F5052FDAQ36433852-08DE8481-4CBE-4A23-B874-AC5866598F13Q37254263-9DE02E3C-2652-4953-820C-E7AC65885E12Q37523519-CB449CE1-B6E9-4258-BA8A-843526DA6EE2Q38073761-8DF6ACB6-BE7F-4549-B1CC-DF5384E01B34Q38297437-DAA3EE66-0366-4AE8-B646-9FE1881E993DQ38315444-93F74405-6D4B-497F-9A6F-70DDE5845C26Q38348963-185B9747-9F32-4108-A8BA-DF4E396313DBQ38703173-D49DC610-1916-43C5-BC7A-54300120EEFEQ38735096-93807F3B-2B04-400B-ACCE-88B20BC5001AQ38752511-5E19F97F-E9B3-479E-8C65-F15F6F3CA3B6Q38970026-54802B22-D0FE-4F52-A9C0-C1BC3ED77E03Q39365643-02A72A80-D9DE-4432-AED8-6A57258A43A5Q39639121-551388BF-8E89-4DCB-B838-A9C4058FED40Q39778958-73E7FFE4-CFFB-4179-BE44-C020650164E9Q39858771-372EFCBF-8DE5-44F4-B751-11B981E538DFQ39860632-F0EB627D-DCA2-4A44-AF16-48DA1CA48DE0Q40072998-646777AF-1635-4EEC-BE97-2BBAB478D44FQ40098067-2DED257D-CA15-42DC-89A0-D9CD8E85E3C3Q42061424-9635A65B-5FDB-49C7-8446-2157D0135030Q42166459-B6262C4D-0B44-4E7D-8C5D-FDF543785CB1
P2860
B cell terminal differentiation factor XBP-1 induces reactivation of Kaposi's sarcoma-associated herpesvirus.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
B cell terminal differentiatio ...... arcoma-associated herpesvirus.
@en
type
label
B cell terminal differentiatio ...... arcoma-associated herpesvirus.
@en
prefLabel
B cell terminal differentiatio ...... arcoma-associated herpesvirus.
@en
P2093
P2860
P1433
P1476
B cell terminal differentiatio ...... arcoma-associated herpesvirus.
@en
P2093
Jiaying Feng
Josephine N Harada
Shannon C Kenney
Sumit K Chanda
P2860
P304
P356
10.1016/J.FEBSLET.2007.06.056
P407
P577
2007-06-29T00:00:00Z